ZYDUSLIFE.BO

Zydus Lifesciences Limited

HealthcareDrug Manufacturers - Specialty & GenericININRPeers →Country macro →

$1,088.90

Jun 05, 2026

AI Brief

Market cap

$1.1T

52w range

—

P / E

—

EPS · FY 2026

$50.09

Volume

—

Revenue · FY 2026

$271.48B

+16.81% YoY

Overview Profile Financials Ratios Multiples Valuation Factors Quant Themes Trend Thesis Committee Earnings Segments Prices Analysts Dividends Corp actions Sentiment ESG

Explain this page

Arphra AIPlain-English read on Zydus Lifesciences Limited’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$1088.90

Change

+23.91%

Period high

$1088.90

Period low

$860.55

Period start

$878.802026-02-01

Through 2026-06-05

Fair value

Football field →

Weighted blend

$1,119.59

— vs spot

Recommendation

n/a

3 of 3 methods

Method spread

0bull0bear

±5% threshold

Insider · 30d

History →

Bought

0 txns

Sold

0 txns

Net flow

+$0

Recent quarters

All financials →

Period	Revenue	Net income	EPS
Q1 Jun 2025	$65.74B	$14.67B	$14.58

Sector & industry today

Live

Sectors

Real Estate
+2.19%
Consumer Cyclical
+1.67%
Consumer Defensive
+1.32%
Communication Services
+0.70%
Healthcare
+0.06%
Industrials
-0.01%
Financial Services
-0.03%
Basic Materials
-0.26%
Utilities
-0.49%
Energy
-1.38%
Technology
-1.70%

Top industries (issuer's industry highlighted)

Drug Manufacturers - Specialty & Generic
+1.31%
Solar
-8.05%
Computer Hardware
-6.29%
Furnishings, Fixtures & Appliances
+4.98%
Silver
-4.53%
Investment - Banking & Investment Services
-4.25%
Hardware, Equipment & Parts
-4.21%
Medical - Equipment & Services
+3.98%
Software - Infrastructure
-3.80%
Oil & Gas Drilling
-3.64%
Coal
-3.59%
Other Precious Metals
-3.44%

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

No recent news for ZYDUSLIFE.BO.

Peers

No peer list available for ZYDUSLIFE.BO.

Total assets

$524.07B

Total debt

$124.96B

Cash & equiv

$14.17B

Operating CF

$21.91B

Free cash flow

-$12.03B

Buybacks

Recent insiders

All →

Insider	Action	Shares	Value	Date
No open-market insider activity in the recent window.

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin
FY 2026	$271.48B	$57.87B	$50.4B	$50.09	+18.56%
FY 2025	$232.42B	$96.04B	$45.26B	$44.97	+19.47%
FY 2024	$195.47B	$75.96B	$38.6B	$37.91	+19.74%